234 related articles for article (PubMed ID: 22705913)
1. A nanoparticle delivery vehicle for S-nitroso-N-acetyl cysteine: sustained vascular response.
Nacharaju P; Tuckman-Vernon C; Maier KE; Chouake J; Friedman A; Cabrales P; Friedman JM
Nitric Oxide; 2012 Oct; 27(3):150-60. PubMed ID: 22705913
[TBL] [Abstract][Full Text] [Related]
2. Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.
Wu W; Gaucher C; Diab R; Fries I; Xiao YL; Hu XM; Maincent P; Sapin-Minet A
Eur J Pharm Biopharm; 2015 Jan; 89():1-8. PubMed ID: 25448077
[TBL] [Abstract][Full Text] [Related]
3. Development of polyethylene glycol-conjugated poly-S-nitrosated serum albumin, a novel S-Nitrosothiol for prolonged delivery of nitric oxide in the blood circulation in vivo.
Katsumi H; Nishikawa M; Yamashita F; Hashida M
J Pharmacol Exp Ther; 2005 Sep; 314(3):1117-24. PubMed ID: 15901798
[TBL] [Abstract][Full Text] [Related]
4. S-nitrosocaptopril nanoparticles as nitric oxide-liberating and transnitrosylating anti-infective technology.
Mordorski B; Pelgrift R; Adler B; Krausz A; da Costa Neto AB; Liang H; Gunther L; Clendaniel A; Harper S; Friedman JM; Nosanchuk JD; Nacharaju P; Friedman AJ
Nanomedicine; 2015 Feb; 11(2):283-91. PubMed ID: 25461287
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
6. Nitrite potentiates the vasodilatory signaling of S-nitrosothiols.
Liu T; Zhang M; Terry MH; Schroeder H; Wilson SM; Power GG; Li Q; Tipple TE; Borchardt D; Blood AB
Nitric Oxide; 2018 May; 75():60-69. PubMed ID: 29428841
[TBL] [Abstract][Full Text] [Related]
7. S-nitrosating nitric oxide donors induce long-lasting inhibition of contraction in isolated arteries.
Alencar JL; Lobysheva I; Chalupsky K; Geffard M; Nepveu F; Stoclet JC; Muller B
J Pharmacol Exp Ther; 2003 Oct; 307(1):152-9. PubMed ID: 12954813
[TBL] [Abstract][Full Text] [Related]
8. Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione.
Friedman AJ; Blecher K; Schairer D; Tuckman-Vernon C; Nacharaju P; Sanchez D; Gialanella P; Martinez LR; Friedman JM; Nosanchuk JD
Nitric Oxide; 2011 Nov; 25(4):381-6. PubMed ID: 21946032
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of human S-nitrosohemoglobin. Effects on oxygen binding and transnitrosation.
Patel RP; Hogg N; Spencer NY; Kalyanaraman B; Matalon S; Darley-Usmar VM
J Biol Chem; 1999 May; 274(22):15487-92. PubMed ID: 10336440
[TBL] [Abstract][Full Text] [Related]
10. S-Nitrosothiols as potential therapeutics to induce a mobilizable vascular store of nitric oxide to counteract endothelial dysfunction.
Perrin-Sarrado C; Zhou Y; Salgues V; Parent M; Giummelly P; Lartaud I; Gaucher C
Biochem Pharmacol; 2020 Mar; 173():113686. PubMed ID: 31678494
[TBL] [Abstract][Full Text] [Related]
11. The relaxation induced by S-nitroso-glutathione and S-nitroso-N-acetylcysteine in rat aorta is not related to nitric oxide production.
Ceron PI; Cremonez DC; Bendhack LM; Tedesco AC
J Pharmacol Exp Ther; 2001 Aug; 298(2):686-94. PubMed ID: 11454932
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of S-nitrosohemoglobin. Mechanisms underlying synthesis, no release, and biological activity.
Wolzt M; MacAllister RJ; Davis D; Feelisch M; Moncada S; Vallance P; Hobbs AJ
J Biol Chem; 1999 Oct; 274(41):28983-90. PubMed ID: 10506146
[TBL] [Abstract][Full Text] [Related]
13. S-nitroso-albumin carries a thiol-labile pool of nitric oxide, which causes venodilation in the rat.
Orie NN; Vallance P; Jones DP; Moore KP
Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H916-23. PubMed ID: 15821033
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of tDodSNO generates a photoactivated nitric oxide releasing nanoparticle for localized control of vasodilation and vascular hyperpermeability.
Alimoradi H; Barzegar-Fallah A; Sammut IA; Greish K; Giles GI
Free Radic Biol Med; 2019 Jan; 130():297-305. PubMed ID: 30367997
[TBL] [Abstract][Full Text] [Related]
15. Ferriheme catalyzes nitric oxide reaction with glutathione to form S-nitrosoglutathione: A novel mechanism for formation of S-nitrosothiols.
Nagababu E
Free Radic Biol Med; 2016 Dec; 101():296-304. PubMed ID: 27693379
[TBL] [Abstract][Full Text] [Related]
16. Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.
Seabra AB; Fitzpatrick A; Paul J; De Oliveira MG; Weller R
Br J Dermatol; 2004 Nov; 151(5):977-83. PubMed ID: 15541075
[TBL] [Abstract][Full Text] [Related]
17. Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols.
Freedman JE; Frei B; Welch GN; Loscalzo J
J Clin Invest; 1995 Jul; 96(1):394-400. PubMed ID: 7615810
[TBL] [Abstract][Full Text] [Related]
18. S-Transnitrosation reactions of hydrogen sulfide (H
Tsikas D; Böhmer A
Nitric Oxide; 2017 May; 65():22-36. PubMed ID: 28185882
[TBL] [Abstract][Full Text] [Related]
19. Structure-reactivity studies of the Cu(2+)-catalyzed decomposition of four S-nitrosothiols based around the S-Nitrosocysteine/S-nitrosoglutathione structures.
Noble DR; Williams DL
Nitric Oxide; 2000 Aug; 4(4):392-8. PubMed ID: 10944424
[TBL] [Abstract][Full Text] [Related]
20. Local and systemic vasodilatory effects of low molecular weight S-nitrosothiols.
Liu T; Schroeder HJ; Wilson SM; Terry MH; Romero M; Longo LD; Power GG; Blood AB
Free Radic Biol Med; 2016 Feb; 91():215-23. PubMed ID: 26686469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
